Alere receives FDA Approval for Alere Determine™ HIV-1/2 Ag/Ab Combo (via PR Newswire)WALTHAM, Mass., Aug. 9, 2013 /PRNewswire/ — Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health information, announced today that it has received…
published: August 12, 2013 in: Approval/Clearance